ERBB2 and neoplasm: The histological type, size, tumor necrosis, lymphovascular invasion, skin, nipple, and chest wall invasion, estrogen receptor (ER) status, progesterone receptor (PR) receptor status, human epidermal growth factor receptor 2 (HER2), cell proliferation marker (ki-67), and type of therapy are the most crucial factors in determining prognosis [7].